We found that participants were appreciative of adaptations of the national AIDS program to ensure continuity of services, such as MMD and home/community‐based ART delivery; however, participants encountered barriers to access facility‐based testing services (HIV antibody testing as well as CD4 and HIV RNA testing) throughout the pandemic. The gene discussed is CD4; the disease is AIDS.